PMID- 26122290 OWN - NLM STAT- MEDLINE DCOM- 20160406 LR - 20181202 IS - 1095-6867 (Electronic) IS - 0018-506X (Linking) VI - 73 DP - 2015 Jul TI - Neuropeptide Y administration reverses tricyclic antidepressant treatment-resistant depression induced by ACTH in mice. PG - 56-63 LID - S0018-506X(15)00109-9 [pii] LID - 10.1016/j.yhbeh.2015.05.018 [doi] AB - Depression is one of the most common mental disorders and a primary cause of disability. To better treat patients suffering this illness, elucidation of the underlying psychopathological and neurobiological mechanisms is urgently needed. Based on the above-mentioned evidence, we sought to investigate the effects of neuropeptide Y (NPY) treatment in tricyclic antidepressant treatment-resistant depression induced by adrenocorticotropic hormone (ACTH) administration. Mice were treated with NPY (5.84, 11.7 or 23.4mmol/mul) intracerebroventricularly (i.c.v.) for one or five days. The levels of serum corticosterone, tryptophan (TRP), kynurenine (KYN), serotonin (5-HT), 5-hydroxyindoleacetic acid (5-HIAA), brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF) and indoleamine 2,3-dioxygenase (IDO) activity in the hippocampus were analyzed. The behavioral parameters (depressive-like and locomotor activity) were also verified. This study demonstrated that ACTH administration increased serum corticosterone levels, KYN, 5-HIAA levels, IDO activity (hippocampus), immobility in the forced swimming test (FST) and the latency to feed in the novelty suppressed feeding test (NSFT). In addition, ACTH administration decreased the BDNF and NGF levels in the hippocampus of mice. NPY treatment was effective in preventing these hormonal, neurochemical and behavioral alterations. It is suggested that the main target of NPY is the modulation of corticosterone and neuronal plasticity protein levels, which may be closely linked with pharmacological action in a model of tricyclic antidepressant treatment-resistant depression. Thus, this study demonstrated a protective effect of NPY on the alterations induced by ACTH administration in mice, indicating that it could be useful as a therapy for the treatment of tricyclic antidepressant treatment-resistant depression. CI - Copyright (c) 2015 Elsevier Inc. All rights reserved. FAU - Antunes, Michelle S AU - Antunes MS AD - Laboratorio de Avaliacoes Farmacologicas e Toxicologicas Aplicadas as Moleculas Bioativas, LaftamBio Pampa, Universidade Federal do Pampa, CEP 97650-000 Itaqui, RS, Brazil. FAU - Ruff, Jossana Rodrigues AU - Ruff JR AD - Laboratorio de Avaliacoes Farmacologicas e Toxicologicas Aplicadas as Moleculas Bioativas, LaftamBio Pampa, Universidade Federal do Pampa, CEP 97650-000 Itaqui, RS, Brazil. FAU - de Oliveira Espinosa, Dieniffer AU - de Oliveira Espinosa D AD - Laboratorio de Avaliacoes Farmacologicas e Toxicologicas Aplicadas as Moleculas Bioativas, LaftamBio Pampa, Universidade Federal do Pampa, CEP 97650-000 Itaqui, RS, Brazil. FAU - Piegas, Manuela Bastos AU - Piegas MB AD - Laboratorio de Avaliacoes Farmacologicas e Toxicologicas Aplicadas as Moleculas Bioativas, LaftamBio Pampa, Universidade Federal do Pampa, CEP 97650-000 Itaqui, RS, Brazil. FAU - de Brito, Maicon Lenon Otenio AU - de Brito ML AD - Laboratorio de Avaliacoes Farmacologicas e Toxicologicas Aplicadas as Moleculas Bioativas, LaftamBio Pampa, Universidade Federal do Pampa, CEP 97650-000 Itaqui, RS, Brazil. FAU - Rocha, Kellen Athaide AU - Rocha KA AD - Laboratorio de Avaliacoes Farmacologicas e Toxicologicas Aplicadas as Moleculas Bioativas, LaftamBio Pampa, Universidade Federal do Pampa, CEP 97650-000 Itaqui, RS, Brazil. FAU - de Gomes, Marcelo Gomes AU - de Gomes MG AD - Laboratorio de Avaliacoes Farmacologicas e Toxicologicas Aplicadas as Moleculas Bioativas, LaftamBio Pampa, Universidade Federal do Pampa, CEP 97650-000 Itaqui, RS, Brazil. FAU - Goes, Andre Tiago Rossito AU - Goes AT AD - Laboratorio de Avaliacoes Farmacologicas e Toxicologicas Aplicadas as Moleculas Bioativas, LaftamBio Pampa, Universidade Federal do Pampa, CEP 97650-000 Itaqui, RS, Brazil. FAU - Souza, Leandro Cattelan AU - Souza LC AD - Laboratorio de Avaliacoes Farmacologicas e Toxicologicas Aplicadas as Moleculas Bioativas, LaftamBio Pampa, Universidade Federal do Pampa, CEP 97650-000 Itaqui, RS, Brazil. FAU - Donato, Franciele AU - Donato F AD - Laboratorio de Avaliacoes Farmacologicas e Toxicologicas Aplicadas as Moleculas Bioativas, LaftamBio Pampa, Universidade Federal do Pampa, CEP 97650-000 Itaqui, RS, Brazil. FAU - Boeira, Silvana Peterini AU - Boeira SP AD - Laboratorio de Avaliacoes Farmacologicas e Toxicologicas Aplicadas as Moleculas Bioativas, LaftamBio Pampa, Universidade Federal do Pampa, CEP 97650-000 Itaqui, RS, Brazil. FAU - Jesse, Cristiano R AU - Jesse CR AD - Laboratorio de Avaliacoes Farmacologicas e Toxicologicas Aplicadas as Moleculas Bioativas, LaftamBio Pampa, Universidade Federal do Pampa, CEP 97650-000 Itaqui, RS, Brazil. Electronic address: cristianoricardojesse@yahoo.com.br. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20150627 PL - United States TA - Horm Behav JT - Hormones and behavior JID - 0217764 RN - 0 (Antidepressive Agents, Tricyclic) RN - 0 (Indoleamine-Pyrrole 2,3,-Dioxygenase) RN - 0 (Neuropeptide Y) RN - 54-16-0 (Hydroxyindoleacetic Acid) RN - 9002-60-2 (Adrenocorticotropic Hormone) RN - W980KJ009P (Corticosterone) SB - IM MH - *Adrenocorticotropic Hormone MH - Animals MH - Antidepressive Agents, Tricyclic/*therapeutic use MH - Corticosterone/blood MH - Depressive Disorder/blood/*chemically induced/*drug therapy MH - Disease Models, Animal MH - Drug Resistance/*drug effects MH - Female MH - Hippocampus/drug effects/metabolism MH - Hydroxyindoleacetic Acid/blood MH - Indoleamine-Pyrrole 2,3,-Dioxygenase/metabolism MH - Mice MH - Mice, Inbred C57BL MH - Neuropeptide Y/administration & dosage/*pharmacology MH - Swimming/physiology OTO - NOTNLM OT - BDNF OT - Hypothalamic-pituitary-adrenocortical OT - Indoleamine 2,3-dioxygenase OT - Kynurenine OT - Neurotrophins OT - Serotonin EDAT- 2015/07/01 06:00 MHDA- 2016/04/07 06:00 CRDT- 2015/07/01 06:00 PHST- 2014/06/27 00:00 [received] PHST- 2015/05/19 00:00 [revised] PHST- 2015/05/28 00:00 [accepted] PHST- 2015/07/01 06:00 [entrez] PHST- 2015/07/01 06:00 [pubmed] PHST- 2016/04/07 06:00 [medline] AID - S0018-506X(15)00109-9 [pii] AID - 10.1016/j.yhbeh.2015.05.018 [doi] PST - ppublish SO - Horm Behav. 2015 Jul;73:56-63. doi: 10.1016/j.yhbeh.2015.05.018. Epub 2015 Jun 27.